age
float64
18
102
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
income
stringclasses
4 values
scoma
float64
0
100
charges
float64
1.17k
1.44M
totcst
float64
0
633k
totmcst
float64
-102.72
711k
avtisst
float64
1
83
race
stringclasses
5 values
sps
float64
0.2
99.2
aps
float64
0
143
surv2m
float64
0
0.97
surv6m
float64
0
0.95
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
prg6m
float64
0
1
dnr
stringclasses
3 values
dnrday
float64
-88
285
meanbp
float64
0
195
wblc
float64
0
200
hrt
float64
0
300
resp
float64
0
90
temp
float64
31.7
41.7
pafi
float64
12
890
alb
float64
0.4
29
bili
float64
0.1
63
crea
float64
0.1
21.5
sod
float64
110
181
ph
float64
6.83
7.77
glucose
float64
0
1.09k
bun
float64
1
300
urine
float64
0
9k
adlp
float64
0
7
adls
float64
0
7
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
event_times
int64
3
2.03k
event_indicators
int64
0
1
69.35498
female
0
12
COPD
COPD/CHF/Cirrhosis
2
12
under $11k
0
9,907
7,324.4648
2,639.72852
13
white
23.296875
23
0.80188
0.679932
1
0
0
no
0.75
0.75
no dnr
12
71
13.798828
130
24
36.5
231.28125
3.199707
0.399963
0.799927
136
7.369141
null
null
null
0
null
adl>=4 (>=5 if sur)
0.4948
523
1
57.435
female
1
5
ARF/MOSF w/Sepsis
ARF/MOSF
4
null
under $11k
44
9,983
7,126.0078
4,083.98828
46
black
33.59375
46
0.439941
0.320984
2
0
0
no
0.5
0.4
dnr before sadm
0
67
4.399414
109
24
35
468
1.699951
11
0.899902
132
7.449219
null
null
null
null
0
<2 mo. follow-up
0
5
1
55.63898
male
1
14
Lung Cancer
Cancer
5
8
under $11k
0
13,241
9,668.6797
4,249.75781
14.666664
white
19.199219
37
0.685913
0.392944
1
0
0
metastatic
0.8
0.7
dnr after sadm
7
77
24.097656
124
30
37.39844
414.25
3.799805
0.599976
1.099854
134
7.40918
null
null
null
0
1
<2 mo. follow-up
1
14
1
36.22198
female
0
14
Cirrhosis
COPD/CHF/Cirrhosis
4
null
null
9
12,878
null
null
10.666664
black
24.398438
27
0.829956
0.7229
1
0
0
no
0.99
0.9
no dnr
14
147
13.199219
114
13
37.79688
294.625
3.299805
2.799805
0.5
141
7.379883
null
null
null
null
1
no(M2 and SIP pres)
1
1,892
0
57.91599
male
0
5
COPD
COPD/CHF/Cirrhosis
3
null
under $11k
0
4,528
3,296.6719
1,637.31934
14
white
21.398438
30
0.879883
0.800903
1
0
0
no
1
1
no dnr
5
63
10.398438
68
24
35.89844
143.3125
3.899902
0.899902
0.899902
132
7.399414
null
null
null
4
0
no(M2 and SIP pres)
0
769
1
59.32397
male
0
24
ARF/MOSF w/Sepsis
ARF/MOSF
3
10
under $11k
0
23,591
17,805.0156
5,815.27734
14.666664
white
31.5
27
0.702881
0.613892
1
0
0
no
0.95
0.95
no dnr
24
119
17.296875
111
28
36.5
232
2.899902
0.5
0.799927
119
7.359375
null
null
null
2
1
no(M2 and SIP pres)
1
1,289
1
71.07196
male
1
5
Coma
Coma
1
null
under $11k
100
14,385
10,782.2812
4,525.02734
46
white
35.796875
54
0.007999
0.003
1
0
0
no
0
0
dnr after sadm
5
63
8.398438
113
20
39.69531
140.59375
2.399902
2
6.399414
126
7.30957
null
null
null
null
null
<2 mo. follow-up
3.21875
5
1
55.17297
male
0
27
MOSF w/Malig
ARF/MOSF
3
null
null
0
15,683
37,632.875
20,804.9375
30.75
white
33.296875
55
0.367981
0.250977
15
0
0
yes
0.7
0.2
dnr after sadm
15
60
0.109985
103
24
36
198.75
2.599609
2.799805
1.599854
135
7.5
null
null
null
2
null
<2 mo. follow-up
1.839
29
1
58.836
female
1
53
ARF/MOSF w/Sepsis
ARF/MOSF
0
6
$11-$25k
0
66,621
48,740.4375
24,677.6094
25
white
25.097656
37
0.774902
0.701904
5
0
0
no
0.5
0.1
dnr after sadm
19
109
11.798828
120
24
38.39844
113.23438
2
0.399963
1
138
7.429688
null
null
null
1
5
<2 mo. follow-up
5
53
1
67.74298
male
0
28
ARF/MOSF w/Sepsis
ARF/MOSF
6
9
null
44
25,813
20,529.9531
7,342.48828
11.25
black
19.199219
28
0.73291
0.650879
2
1
0
no
0.7
0.5
dnr after sadm
7
79
11.898438
100
12
38.29688
250
3.199707
1.299805
1.099854
134
7.429688
null
null
null
null
4
adl>=4 (>=5 if sur)
4
221
1
44.47098
male
0
26
ARF/MOSF w/Sepsis
ARF/MOSF
3
16
>$50k
9
29,825
23,189.625
5,431.4375
12
white
28.898438
33
0.73291
0.649902
7
0
0
no
0.6
0.5
no dnr
26
108
13
129
36
38.59375
157.9375
2.299805
0.299988
0.799927
130
7.389648
null
null
null
null
0
no(M2 and SIP pres)
0
1,886
0
19.44099
female
0
27
ARF/MOSF w/Sepsis
ARF/MOSF
2
11
>$50k
89
26,602
19,745.0312
8,173.22656
23
white
28.699219
48
0.525879
0.409973
2
0
0
yes
0.7
0.5
dnr after sadm
1
120
10.199219
153
60
39.29688
217.65625
3
0.399963
0.599976
131
7.469727
null
null
null
null
7
adl>=4 (>=5 if sur)
7
73
1
28.85699
male
0
23
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$25-$50k
0
48,348
33,997.0312
16,042.3984
52
white
32.5
45
0.80896
0.745972
1
0
0
no
0.5
0.5
no dnr
23
75
10.398438
115
16
39.19531
93.28125
2.799805
4.799805
1.5
141
7.279297
null
null
null
null
0
no(M2 and SIP pres)
0
1,886
0
46.57098
male
0
14
Cirrhosis
COPD/CHF/Cirrhosis
2
8
$11-$25k
9
10,517
8,146.3789
2,516.6582
4.666664
white
17.898438
32
0.860962
0.769897
1
0
0
no
0.5
0.3
no dnr
14
72
9.099609
88
22
37.79688
331.875
2.199707
3.899902
0.699951
134
7.459961
null
null
null
0
2
no(M2 and SIP pres)
2
1,884
0
66.49396
female
0
4
Lung Cancer
Cancer
3
8
null
9
2,963
2,225.7715
1,004.52979
6
white
21.699219
26
0.556885
0.233978
1
0
0
metastatic
null
null
dnr before sadm
0
103
8
77
24
36.5
null
null
0.199982
1.899902
126
null
null
null
null
null
1
<2 mo. follow-up
1
21
1
68.69299
female
0
8
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
under $11k
0
10,490
7,969.9062
2,740.56836
16.5
white
29.398438
32
0.699951
0.609985
1
0
1
no
1
0.8
dnr before sadm
-1
108
14.298828
136
36
38.5
177.125
4.299805
0.799927
0.699951
130
7.419922
null
null
null
null
4
no(M2 and SIP pres)
4
344
1
56.85397
female
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
2
10
$11-$25k
0
12,699
9,728.1484
2,626.26953
15.666664
white
24.796875
49
0.822998
0.762939
1
1
0
no
1
0.95
no dnr
15
131
12.699219
83
31
35.69531
314.8125
2.199707
0.199982
2.5
133
7.389648
null
null
null
5
6
no(M2 and SIP pres)
6
236
1
65.26495
male
1
5
CHF
COPD/CHF/Cirrhosis
5
12
$11-$25k
44
16,432
13,072.0391
2,839.25977
39
white
46.898438
71
0.046997
0.004999
5
0
0
no
0.1
0.001
dnr after sadm
3
46
18.5
160
38
39
111.625
2.799805
1.199951
1.5
131
7.349609
null
null
null
null
0
<2 mo. follow-up
0
5
1
38.43698
male
0
16
MOSF w/Malig
ARF/MOSF
1
12
under $11k
44
44,481
31,427.0938
11,756.7266
40
white
30.898438
45
0.17099
0.085999
12
0
0
metastatic
0.75
0.421875
no dnr
16
57
28.398438
109
28
38.69531
124.4375
2
0.799927
0.899902
130
7.469727
null
null
null
null
5
null
5
69
1
89.36096
female
0
4
CHF
COPD/CHF/Cirrhosis
2
12
under $11k
9
2,386
1,827.4287
497.1499
4
black
16.5
16
0.803955
0.682983
1
0
0
no
0.9
0.7
no dnr
4
99
6.699219
66
20
36
442.8125
3.599609
0.399963
1.5
136
7.459961
null
null
null
1
0
SIP>=30
0
607
1
62.93997
female
0
10
CHF
COPD/CHF/Cirrhosis
4
11
under $11k
0
11,791
9,143.8281
2,908.06836
11.5
white
19.699219
20
0.869995
0.784912
1
0
0
no
0.8
0.5
dnr after sadm
1
110
6.199219
62
34
36.29688
396.25
3.199707
0.5
1.399902
136
7.449219
null
null
null
3
5
<2 mo. follow-up
5
32
1
65.55499
male
1
3
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
100
49,916
35,438.4375
15,968.5938
69
black
64.796875
91
0
0
18
0
0
yes
0
0
no dnr
3
31
58.59375
0
36
38.29688
52
2.699707
5.699219
0.599976
132
7.119141
null
null
null
null
null
<2 mo. follow-up
2.962402
3
1
57.62399
female
0
35
ARF/MOSF w/Sepsis
ARF/MOSF
0
16
under $11k
0
71,696
56,249.2812
13,051.2188
27.75
white
25.796875
20
0.764893
0.688965
6
0
0
no
0.75
0.5
dnr after sadm
1
115
19
136
12
38.79688
233.96875
2.899902
0.5
0.399963
131
7.339844
null
null
null
null
4
SIP>=30
4
1,879
0
77.77698
male
0
6
Lung Cancer
Cancer
3
null
under $11k
9
4,039
3,098.3418
1,024.61914
10
black
35.195313
17
0.141998
0.007999
1
0
0
metastatic
null
null
no dnr
6
96
11.599609
102
20
35
null
2.699707
0.199982
0.799927
127
null
null
null
null
null
7
<2 mo. follow-up
7
18
1
57.16898
male
0
36
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
under $11k
44
43,385
33,680.7812
14,684.6875
23.25
white
26.398438
57
0.657959
0.559937
1
0
0
no
0.8
0.75
dnr after sadm
4
55
20.199219
68
24
36.89844
342.8125
2.399902
0.399963
3.299805
133
7.289062
null
null
null
null
6
adl>=4 (>=5 if sur)
6
1,548
1
70.64795
female
0
9
ARF/MOSF w/Sepsis
ARF/MOSF
0
11
under $11k
0
11,537
8,542.9219
2,377.1582
13
white
20.898438
20
0.829956
0.772949
1
0
0
no
0.9
0.7
no dnr
9
69
11
55
24
36.89844
185
3.699707
0.399963
0.899902
134
7.469727
null
null
null
0
0
no(M2 and SIP pres)
0
504
1
68.12897
male
1
24
Coma
Coma
3
null
null
100
33,190
24,041.8281
10,818.4375
25.333328
white
25
32
0.154999
0.102997
1
0
0
no
0.4
0.3
dnr after sadm
6
63
9.898438
77
12
36.39844
143.3125
4
1.5
1.899902
133
7.379883
null
null
null
null
null
<2 mo. follow-up
3.589356
24
1
19.17599
male
0
18
ARF/MOSF w/Sepsis
ARF/MOSF
1
9
null
0
23,266
17,812.2812
5,496.71875
14.666664
black
25.097656
26
0.888916
0.849976
5
0
0
no
0.99
0.99
no dnr
18
74
22.398438
111
48
36.59375
320
3.099609
1.699951
0.599976
137
7.419922
null
null
null
null
null
null
2.98877
1,876
0
44.698
male
1
12
MOSF w/Malig
ARF/MOSF
1
12
$25-$50k
0
null
null
null
26
white
33.195313
47
0.506958
0.389954
1
0
0
yes
0.75
0.5
null
null
105
0.309998
58
28
36.29688
null
3.099609
1.199951
1.899902
130
null
null
null
null
2
0
<2 mo. follow-up
0
12
1
68.13098
female
0
6
MOSF w/Malig
ARF/MOSF
2
13
under $11k
0
23,735
16,893.375
6,256.94922
34
black
25.898438
38
0.494995
0.377991
8
0
0
metastatic
0.25
0.1
no dnr
6
65
16.898438
106
22
36
141.71875
2.099609
0.699951
0.799927
139
7.189453
null
null
null
0
0
SIP>=30
0
79
1
75.64996
female
0
17
COPD
COPD/CHF/Cirrhosis
3
13
null
0
16,397
12,036.5859
5,585.35938
20.666656
white
31.296875
48
0.590942
0.399963
1
1
0
no
0.9
0.9
dnr before sadm
-1
121
43.09375
114
36
36.39844
319.1875
2.399902
0.799927
0.899902
140
7.419922
null
null
null
null
6
adl>=4 (>=5 if sur)
6
323
1
50.90198
male
0
6
CHF
COPD/CHF/Cirrhosis
5
10
under $11k
0
4,139
3,192.3516
1,036.26953
11
black
22.398438
32
0.875977
0.794922
1
0
0
no
0.7
0.7
no dnr
6
106
6.099609
66
25
36
347.5625
3.799805
1.699951
1.899902
130
7.439453
null
null
null
2
2
<2 mo. follow-up
2
59
1
61.46997
male
0
24
CHF
COPD/CHF/Cirrhosis
6
5
under $11k
0
17,282
13,229.7422
3,165.04883
11
black
24.097656
38
0.824951
0.715942
1
0
0
no
0.8
0.6
no dnr
24
81
4.299805
65
24
35.19531
null
4.099609
9.699219
1.599854
133
null
null
null
null
3
null
SIP>=30
2.511099
1,423
1
31.778
female
0
5
ARF/MOSF w/Sepsis
ARF/MOSF
0
8
under $11k
0
8,632
6,479.1289
4,165.17969
16
hispanic
21.699219
15
0.898926
0.861938
3
0
0
no
1
1
no dnr
5
85
13.599609
107
16
35.5
360
2.699707
0.099991
0.799927
143
7.279297
null
null
null
0
0
no(M2 and SIP pres)
0
1,871
0
58.90997
male
0
12
CHF
COPD/CHF/Cirrhosis
5
8
$11-$25k
0
6,866
5,545.7188
6,756.72656
9
white
24.5
32
0.828979
0.719971
1
1
0
no
0.9
0.9
no dnr
12
107
7.899414
72
20
36.19531
null
2.599609
0.399963
2.099609
134
null
null
null
null
1
null
no(M2 and SIP pres)
1.1669
469
1
59.94299
male
0
7
CHF
COPD/CHF/Cirrhosis
6
8
null
0
5,369
4,071.6289
985.38965
17
white
19.097656
36
0.883911
0.805908
1
1
0
no
0.3
0.25
dnr after sadm
2
67
8.5
58
22
35.5
276.1875
3.699707
1
1.599854
137
7.459961
null
null
null
2
3
null
3
389
1
44.36697
female
1
7
Coma
Coma
1
9
under $11k
44
34,994
27,346.5156
6,801.59766
46
white
21.398438
31
0.635986
0.574951
24
1
0
no
0
0
dnr after sadm
1
119
9.199219
122
44
38.29688
310
3.299805
0.299988
0.599976
136
7.519531
null
null
null
null
6
<2 mo. follow-up
6
7
1
56.82397
male
1
4
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
under $11k
0
11,003
8,158.1055
3,571.9082
47
white
51.09375
80
0.192993
0.10199
1
0
0
no
0.75
0.75
dnr after sadm
4
40
18.597656
104
42
36.69531
128.3125
1.899902
1.5
4.799805
128
7.279297
null
null
null
null
0
<2 mo. follow-up
0
4
1
69.81799
male
0
28
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$11-$25k
0
67,894
51,587.5938
24,316.0781
27.25
white
20.097656
17
0.81189
0.748901
5
0
0
no
0.98
0.98
no dnr
28
76
8
64
6
36.59375
190
2
0.799927
1.099854
127
7.439453
null
null
null
0
0
no(M2 and SIP pres)
0
782
1
40.82098
female
0
12
ARF/MOSF w/Sepsis
ARF/MOSF
1
13
under $11k
0
22,096
16,272.7656
6,460.19922
30
black
26.296875
56
0.810913
0.746948
8
0
0
no
0.6
0.4
no dnr
12
62
27.199219
157
12
37.59375
330
1.799805
0.399963
0.299988
155
7.269531
null
null
null
null
7
adl>=4 (>=5 if sur)
7
1,870
0
61.862
female
0
10
Cirrhosis
COPD/CHF/Cirrhosis
2
16
$11-$25k
0
7,547
5,688.0742
1,851.94922
10.5
white
23.699219
34
0.714966
0.556885
1
0
0
no
0.95
1
no dnr
10
65
18.097656
78
24
36.59375
null
2.899902
8.099609
0.699951
134
null
null
null
null
null
null
no(M2 and SIP pres)
3.489746
1,867
0
58.21799
male
0
3
Lung Cancer
Cancer
1
10
under $11k
0
2,678
1,860.1299
1,129.20996
15
white
5.299805
9
0.882935
0.733887
1
0
0
metastatic
0.8
0.5
no dnr
3
93
6.099609
82
20
36.59375
null
4.399414
0.5
0.599976
137
null
null
null
null
null
null
no(M2 and SIP pres)
1.901856
392
1
62.85797
female
0
54
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
under $11k
0
101,794
73,628.625
71,763
44.5
white
28.796875
42
0.706909
0.618896
3
0
0
no
0.65
0.65
no dnr
54
60
5.399414
135
25
38.29688
92.84375
2
0.5
1.099854
137
7.359375
null
null
null
null
0
no(M2 and SIP pres)
0
1,867
0
54.09198
male
0
20
Cirrhosis
COPD/CHF/Cirrhosis
5
11
under $11k
37
22,227
16,526.3438
6,487.08984
13.333328
white
25.597656
43
0.590942
0.399963
1
1
0
no
0.8
0.6
dnr after sadm
9
75
6.899414
124
24
36
476.1875
2.599609
3.899902
1.699951
142
7.5
null
null
null
null
0
no(M2 and SIP pres)
0
1,865
0
65.72797
female
0
5
CHF
COPD/CHF/Cirrhosis
3
11
under $11k
0
3,533
2,659.3281
882.76953
10
black
20.898438
33
0.849976
0.75293
1
0
0
no
0.6
0.5
no dnr
5
104
7.299805
60
32
36.19531
242.84375
null
0.899902
1.899902
142
7.419922
null
null
null
0
null
<2 mo. follow-up
0.4948
33
1
76.38898
female
0
18
ARF/MOSF w/Sepsis
ARF/MOSF
1
8
under $11k
0
36,207
26,361.5625
10,101.8281
13.333328
white
25
42
0.685913
0.592896
8
0
0
no
0.85
0.75
no dnr
18
103
15.898438
101
20
36.29688
310
1.899902
1.599854
2.5
135
7.349609
null
null
null
0
0
no(M2 and SIP pres)
0
1,866
0
59.13498
female
0
5
Cirrhosis
COPD/CHF/Cirrhosis
2
12
under $11k
0
3,112
2,397.3359
700.76953
10
white
20.699219
35
0.784912
0.654907
1
0
0
no
0.9
0.8
no dnr
5
62
6.799805
120
23
36.59375
null
2.599609
2.099609
1.299805
135
null
null
null
null
0
2
no(M2 and SIP pres)
2
1,401
1
55.474
female
0
94
ARF/MOSF w/Sepsis
ARF/MOSF
0
8
$11-$25k
0
212,445
164,982.375
159,981.625
44.5
white
27.296875
72
0.792969
0.724976
1
1
0
no
0.5
0.5
no dnr
94
61
11.199219
133
36
38.5
426
2
2.299805
2.099609
136
7.469727
null
null
null
null
3
adl>=4 (>=5 if sur)
3
257
1
54.146
female
0
8
MOSF w/Malig
ARF/MOSF
1
12
null
0
27,282
19,477.1719
9,371.72656
21.5
white
36.59375
45
0.264954
0.15799
19
0
0
yes
0.95
0.95
no dnr
8
91
0
140
28
39
null
2.5
1.399902
0.799927
125
null
null
null
null
0
6
no(M2 and SIP pres)
6
524
1
54.883
female
0
6
CHF
COPD/CHF/Cirrhosis
4
10
under $11k
0
5,706
4,203.7383
2,311.34961
10
black
28.199219
34
0.792969
0.667969
1
1
0
no
0.98
0.95
no dnr
6
113
8.298828
104
24
36.29688
252.375
2.599609
0.399963
2.5
137
7.359375
null
null
null
5
null
null
3.855299
261
1
65.659
male
0
51
ARF/MOSF w/Sepsis
ARF/MOSF
2
10
null
0
71,701
55,313.6562
55,616.75
21.75
white
38
58
0.401978
0.282959
12
1
1
no
0.5
0.5
no dnr
51
53
6.399414
118
28
35.59375
133.25
2.099609
0.399963
1.699951
130
7.489258
null
null
null
null
1
no(M2 and SIP pres)
1
251
1
72.13098
female
0
10
COPD
COPD/CHF/Cirrhosis
4
12
under $11k
0
7,997
5,999.3281
2,242.41992
12.5
white
20.398438
23
0.782959
0.651978
1
0
0
yes
0.5
0.4
dnr after sadm
1
76
6.099609
114
24
36.59375
202
3.399902
0.899902
1
136
7.349609
null
null
null
null
4
adl>=4 (>=5 if sur)
4
1,859
0
61.75998
male
0
7
COPD
COPD/CHF/Cirrhosis
3
0
under $11k
0
5,883
4,348.332
1,688.12988
8
white
20.898438
38
0.869995
0.783936
1
0
0
no
0.3
0.1
dnr after sadm
2
71
6.199219
104
22
36.29688
189.1875
null
null
1.399902
137
7.239258
null
null
null
2
6
<2 mo. follow-up
6
15
1
59.61099
female
0
9
CHF
COPD/CHF/Cirrhosis
4
10
under $11k
0
8,314
6,497.7617
1,861.3291
10.5
white
20.097656
17
0.875977
0.792969
1
1
0
no
0.95
0.9
no dnr
9
106
9.5
110
22
36
372
3.699707
1.199951
0.799927
134
7.379883
null
null
null
6
4
SIP>=30
4
81
1
61.76898
female
1
27
ARF/MOSF w/Sepsis
ARF/MOSF
3
10
under $11k
44
105,139
75,388.625
43,017.6875
53.75
white
32.195313
58
0.389954
0.270996
7
1
0
no
0.5
0.5
dnr after sadm
27
71
16.097656
128
30
38
92.29688
2.399902
3.899902
1
143
7.5
null
null
null
null
1
<2 mo. follow-up
1
27
1
70.24194
female
0
6
CHF
COPD/CHF/Cirrhosis
4
3
null
0
4,524
3,394.2441
1,397.36914
12
black
10.798828
19
0.92395
0.870972
1
0
0
no
0.9
0.9
no dnr
6
106
9.798828
98
22
36
369.5
4.599609
0.699951
1.099854
142
7.389648
null
null
null
0
0
no(M2 and SIP pres)
0
1,857
0
47.51297
male
0
12
CHF
COPD/CHF/Cirrhosis
3
12
under $11k
0
16,698
12,657.3438
3,547.7793
22
black
35.195313
40
0.641968
0.461975
7
0
0
no
0.8
0.5
no dnr
12
121
10.5
101
14
35.59375
480.4375
2.799805
1.399902
6.699219
126
7.489258
null
null
null
0
4
SIP>=30
4
1,855
0
80.76898
female
1
20
ARF/MOSF w/Sepsis
ARF/MOSF
0
7
under $11k
0
43,134
33,944.875
8,631.48438
29
white
42.898438
50
0.260986
0.154999
1
0
0
no
0.5
0.25
dnr after sadm
2
48
16.699219
101
20
36.19531
108.32812
1.699951
2
0.5
126
7.389648
null
null
null
null
null
<2 mo. follow-up
2.75
20
1
59.995
female
0
11
Cirrhosis
COPD/CHF/Cirrhosis
2
12
under $11k
0
16,998
13,500.625
7,232.92969
21.5
null
25.097656
37
0.680908
0.511963
2
0
0
no
0.98
0.9
no dnr
11
104
8.699219
110
30
36.79688
288.875
2.699707
6.299805
1
133
7.399414
null
null
null
0
0
no(M2 and SIP pres)
0
1,854
0
60.487
female
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
5
10
null
0
46,234
38,764.875
13,882.6562
17.333328
white
30.898438
38
0.571899
0.460999
7
1
1
yes
1
0.8
no dnr
14
127
11.798828
50
10
36.59375
146.25
null
null
3
134
7.40918
null
null
null
null
null
no(M2 and SIP pres)
5.280273
875
1
75.58099
female
0
8
CHF
COPD/CHF/Cirrhosis
4
12
under $11k
0
8,458
6,429.4102
3,675.22852
15.5
white
19.898438
35
0.829956
0.7229
1
1
0
no
0.7
0.5
no dnr
8
82
7.099609
72
20
35.69531
394.75
3.399902
4
2
134
7.40918
null
null
null
3
1
SIP>=30
1
496
1
77.44598
female
0
24
Colon Cancer
Cancer
2
10
under $11k
0
17,083
13,181.4922
3,600.2793
12.333328
white
15
16
0.820923
0.613892
1
0
0
metastatic
0.5
0.3
no dnr
24
96
7.099609
96
20
37
null
3.299805
0.699951
1.099854
136
null
null
null
null
3
0
SIP>=30
0
144
1
66.34399
female
1
14
Lung Cancer
Cancer
1
12
under $11k
0
10,776
8,134.1602
2,660.4082
20.666656
white
30.699219
53
0.343994
0.070999
1
0
0
metastatic
0.05
0.000125
dnr after sadm
3
59
15.599609
106
40
35.29688
170
1.699951
0.299988
0.799927
138
7.25
null
null
null
0
0
<2 mo. follow-up
0
14
1
48.76398
male
0
5
COPD
COPD/CHF/Cirrhosis
5
8
under $11k
0
4,564
3,269.1152
1,649.13965
17
white
12.599609
24
0.954956
0.92395
1
0
0
no
1
0.75
no dnr
5
78
20.597656
75
24
35.59375
208
4.599609
0.699951
1
136
7.229492
null
null
null
0
null
no(M2 and SIP pres)
0.4948
369
1
47.64999
male
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
null
0
18,079
13,855.7578
7,969.97656
20
white
29.097656
32
0.767944
0.69397
3
0
0
no
0.9
0.9
no dnr
11
107
15.699219
110
28
36.29688
147.5
null
1.5
1
132
7.419922
null
null
null
0
null
no(M2 and SIP pres)
0.4948
1,847
0
68.93896
male
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
2
3
under $11k
0
26,031
20,241.2969
5,496.14844
34.333313
white
22.5
30
0.815918
0.753906
1
0
0
no
0.9
0.5
dnr after sadm
10
106
null
106
38
36.09375
187.5
3
0.699951
1.099854
142
7.349609
null
null
null
null
null
no(M2 and SIP pres)
2.572754
326
1
67.55896
male
0
12
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
$11-$25k
9
30,357
22,907.75
6,930.06641
17.5
white
34.195313
44
0.473999
0.35498
7
0
0
no
0.9
0.6
no dnr
12
139
17.5
100
24
35.09375
115
2.599609
0.899902
8
134
7.40918
null
null
null
0
0
<2 mo. follow-up
0
44
1
55.82999
female
0
12
Cirrhosis
COPD/CHF/Cirrhosis
2
12
under $11k
0
8,649
6,666.0781
2,036.46973
2.5
white
22.898438
31
0.769897
0.633911
1
0
0
no
0.8
0.7
no dnr
12
76
5.899414
94
22
37.59375
null
2
6
0.799927
129
null
null
null
null
0
0
no(M2 and SIP pres)
0
124
1
81.25098
female
0
10
CHF
COPD/CHF/Cirrhosis
4
8
under $11k
0
7,897
5,884.1719
2,308.66992
16.5
white
23.796875
55
0.747925
0.602905
1
0
0
no
0.95
0.85
no dnr
10
67
14.099609
68
32
36.69531
230.46875
3.899902
1.199951
2.899902
130
7.369141
null
null
null
0
null
null
0.4948
285
1
48.92798
male
0
9
CHF
COPD/CHF/Cirrhosis
5
16
under $11k
0
9,129
6,780.3516
2,588.39844
19.5
black
23
37
0.875977
0.792969
1
0
0
no
0.9
0.8
no dnr
9
129
3.799805
80
16
36.29688
382.8125
3.099609
0.5
3
135
7.349609
null
null
null
0
3
SIP>=30
3
1,839
0
77.73895
male
1
32
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
under $11k
61
74,682
53,243
54,324.0625
32.75
white
27.199219
41
0.309998
0.196991
14
1
0
no
0.8
0.5
no dnr
32
102
14.199219
117
36
39.89844
433.3125
2.399902
0.299988
0.599976
130
7.479492
null
null
null
null
1
<2 mo. follow-up
1
32
1
61.19897
male
1
60
ARF/MOSF w/Sepsis
ARF/MOSF
5
10
under $11k
0
67,041
51,980.4375
49,886.2188
21.5
white
30.199219
39
0.720947
0.634888
1
0
0
no
0.8
0.5
dnr after sadm
43
103
15.199219
111
12
37.79688
126
2.699707
0.699951
6.699219
143
7.449219
null
null
null
null
2
null
2
60
1
64.34497
female
1
138
ARF/MOSF w/Sepsis
ARF/MOSF
5
12
null
0
400,010
313,637.5
306,945
49
white
26
41
0.592896
0.484985
8
0
0
metastatic
0.8
0.4
dnr after sadm
112
65
10.199219
114
12
36.5
146.15625
2.399902
0.5
1.599854
138
7.539062
null
null
null
null
0
adl>=4 (>=5 if sur)
0
138
1
29.62399
female
0
6
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
under $11k
0
6,229
4,874.7773
1,568.46973
15
black
17.199219
30
0.939941
0.917969
1
1
0
no
0.99
1
no dnr
6
62
9.298828
48
24
37
528.5
3
0.199982
0.799927
137
7.199219
null
null
null
0
null
<2 mo. follow-up
0.4948
25
1
22.20399
female
0
202
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$25-$50k
0
290,573
223,134.375
234,875.875
35
white
28.699219
44
0.81897
0.757935
35
0
0
no
0.3
0.3
no dnr
202
144
17.898438
189
28
37.79688
157.5
3
0.599976
0.599976
133
7.65918
null
null
null
null
6
adl>=4 (>=5 if sur)
6
1,837
0
43.064
female
0
23
ARF/MOSF w/Sepsis
ARF/MOSF
1
9
under $11k
0
50,118
38,679.25
36,925.8125
31.333328
white
28.5
45
0.786987
0.716919
4
1
0
no
0.6
0.6
no dnr
23
68
15.298828
129
30
37.79688
118.71875
2.199707
0.799927
1.099854
134
7.379883
null
null
null
null
0
no(M2 and SIP pres)
0
1,826
0
56.23297
male
0
25
ARF/MOSF w/Sepsis
ARF/MOSF
3
10
$11-$25k
0
41,357
32,244.8281
31,959.9531
17
black
23.097656
44
0.845947
0.792969
1
0
0
no
0.9
0.8
no dnr
25
68
9.898438
80
16
35.89844
366.625
4
2
10.298828
131
7.389648
null
null
null
0
4
no(M2 and SIP pres)
4
1,826
0
72.91998
female
0
10
MOSF w/Malig
ARF/MOSF
3
8
under $11k
0
8,968
6,329.0781
6,522.59766
12
white
22.898438
26
0.645996
0.545898
1
0
0
metastatic
0.25
0.1
dnr after sadm
2
101
19.699219
108
20
36.29688
266.625
2
1
0.5
137
7.279297
null
null
null
null
7
<2 mo. follow-up
7
17
1
64.52594
female
0
12
MOSF w/Malig
ARF/MOSF
1
10
$11-$25k
0
17,900
14,150.2969
13,078.3438
35
white
26.796875
59
0.636963
0.534912
1
0
0
yes
0.5
0.5
no dnr
12
67
13.099609
107
14
36.69531
356.625
1.799805
3
2.899902
139
7.329102
null
null
null
null
null
no(M2 and SIP pres)
2.302246
1,041
1
66.11896
female
0
5
Lung Cancer
Cancer
2
12
under $11k
0
4,149
2,941.3828
2,864.25977
9
black
18.199219
15
0.680908
0.385986
1
1
0
metastatic
0.8
0.3
dnr after sadm
1
95
10.5
66
24
37.79688
257.125
3.199707
0.399963
0.699951
139
7.469727
null
null
null
0
0
no(M2 and SIP pres)
0
236
1
73.71698
female
0
6
Lung Cancer
Cancer
1
12
null
0
3,515
2,652.0137
2,428.92969
7
white
28.199219
35
0.393982
0.099991
1
0
0
metastatic
0.5
0.4
dnr after sadm
1
76
7.099609
114
24
36.39844
227.125
3
0.399963
0.5
132
7.469727
null
null
null
6
5
<2 mo. follow-up
5
26
1
64.849
female
0
20
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
under $11k
44
37,256
28,256.3594
27,181.4375
29
black
35.296875
55
0.303955
0.191986
4
0
0
no
0.3
0.2
no dnr
20
54
12.398438
111
30
35
300
2.699707
1.599854
2.799805
142
7.40918
null
null
null
5
5
adl>=4 (>=5 if sur)
5
54
1
68.85095
male
0
16
ARF/MOSF w/Sepsis
ARF/MOSF
2
11
under $11k
0
15,825
11,496.8828
11,094.9531
16
white
24.398438
34
0.689941
0.5979
5
0
0
yes
0.9
0.8
no dnr
16
85
11.199219
56
20
36.09375
275
2.299805
6.399414
1.199951
138
7.519531
null
null
null
null
0
adl>=4 (>=5 if sur)
0
1,821
0
65.487
female
0
4
Lung Cancer
Cancer
3
11
null
0
7,190
2,025.7129
1,854.90918
15
black
10.798828
17
0.809937
0.593994
1
0
0
metastatic
0.25
0.05
dnr after sadm
1
103
3.599609
108
20
36.5
267.5625
4.099609
0.699951
0.899902
139
7.389648
null
null
null
0
null
<2 mo. follow-up
0.4948
28
1
73.32495
female
0
5
CHF
COPD/CHF/Cirrhosis
5
14
under $11k
0
3,602
2,656.4199
2,451.34961
9
black
21.097656
32
0.779907
0.647949
1
1
0
yes
1
0.7
no dnr
5
119
7.599609
78
24
36
386.1875
3.399902
0.299988
3.699707
139
7.369141
null
null
null
0
1
no(M2 and SIP pres)
1
1,070
1
51.26099
male
0
6
CHF
COPD/CHF/Cirrhosis
3
8
under $11k
0
5,223
3,622.3848
4,110.12891
16
black
12.898438
15
0.939941
0.897949
1
0
0
no
1
0.85
no dnr
6
75
8.798828
96
24
36
314.75
4.199219
1.199951
1
137
7.399414
null
null
null
4
5
null
5
1,409
1
50.69098
female
0
10
Lung Cancer
Cancer
4
11
$11-$25k
0
9,506
6,553.1758
6,873.66797
13
black
16.5
44
0.748901
0.488953
1
0
0
metastatic
0.6
0.3
no dnr
10
60
0.899902
112
30
39.19531
352.375
3.699707
0.599976
0.899902
138
7.389648
null
null
null
4
0
SIP>=30
0
79
1
66.67999
female
1
20
ARF/MOSF w/Sepsis
ARF/MOSF
1
6
under $11k
0
57,846
41,928.1875
44,372.3125
46.666657
white
39.5
71
0.334961
0.219971
19
0
0
no
0.2
0.2
dnr after sadm
19
125
23
120
28
35.5
230.65625
2.799805
11.298828
2.099609
128
7.40918
null
null
null
null
0
<2 mo. follow-up
0
20
1
67.27399
female
1
18
MOSF w/Malig
ARF/MOSF
3
null
null
44
55,395
39,613.875
37,132.875
53.666657
white
35.695313
66
0.047997
0.014999
12
1
0
metastatic
0.5
0
dnr after sadm
16
54
12.398438
130
24
38.29688
98.79688
1.699951
2.599609
1.5
132
7.449219
null
null
null
null
null
<2 mo. follow-up
4.148438
18
1
56.80197
male
0
8
Cirrhosis
COPD/CHF/Cirrhosis
3
13
under $11k
0
5,660
4,237.1289
3,937.18945
5.5
white
24.796875
36
0.730957
0.578979
1
1
0
no
0.95
0.9
no dnr
8
73
13.398438
72
16
38.19531
null
3.099609
8.599609
0.599976
130
null
null
null
null
5
4
no(M2 and SIP pres)
4
1,657
1
62.672
female
0
17
Cirrhosis
COPD/CHF/Cirrhosis
2
12
$25-$50k
0
14,477
10,420.1484
8,907.67969
8.333328
white
24.699219
34
0.689941
0.522949
1
0
0
no
0.9
0.8
no dnr
17
75
13.199219
62
28
36.59375
342.8125
2.899902
4.299805
0.699951
131
7.469727
null
null
null
null
null
no(M2 and SIP pres)
3.400879
1,819
0
63.81897
male
1
4
ARF/MOSF w/Sepsis
ARF/MOSF
4
null
null
41
34,153
25,040.625
25,694.5156
78
black
42.898438
87
0.084
0.032997
20
1
0
no
null
null
no dnr
4
141
17.5
144
50
38.69531
70.1875
2.5
0.899902
4.699219
131
7.239258
null
null
null
null
null
<2 mo. follow-up
3.804199
4
1
54.13599
male
0
13
ARF/MOSF w/Sepsis
ARF/MOSF
2
9
under $11k
41
18,031
15,195.3438
14,238.0234
26.5
black
23.097656
20
0.747925
0.668945
1
0
0
no
0.8
0.7
no dnr
13
119
17
131
30
38.59375
217.9375
2.5
0.399963
0.599976
139
7.389648
null
null
null
null
6
null
6
1,363
1
70.52997
female
0
16
ARF/MOSF w/Sepsis
ARF/MOSF
4
10
under $11k
0
27,348
19,935.2812
19,630.7812
16.666656
white
30.796875
40
0.501953
0.384949
9
1
0
yes
0.95
0.85
no dnr
16
131
16
114
30
36
114.28125
2.5
0.599976
1.099854
133
7.449219
null
null
null
1
1
no(M2 and SIP pres)
1
1,816
0
65.94397
female
1
43
Cirrhosis
COPD/CHF/Cirrhosis
2
12
under $11k
0
43,172
32,274.2969
30,522
8
black
23
28
0.699951
0.536987
1
0
0
no
0.5
0.25
no dnr
43
119
5.299805
104
20
36.39844
null
2.199707
6.899414
0.899902
138
null
null
null
null
0
0
<2 mo. follow-up
0
43
1
61.69998
female
1
9
Coma
Coma
2
null
null
100
39,025
31,000.5625
29,116.8906
44
white
26.097656
43
0.100998
0.059998
12
0
0
no
0.2
0.1
dnr after sadm
4
145
20.597656
153
32
40.29688
242.71875
2.299805
0.399963
0.599976
147
7.399414
null
null
null
null
null
<2 mo. follow-up
3.353516
9
1
75.83295
female
1
11
MOSF w/Malig
ARF/MOSF
2
6
under $11k
100
14,140
10,036.8438
10,409.5391
18.5
black
29.296875
75
0.021
0.004999
5
0
0
metastatic
0.1
0.001
dnr after sadm
3
70
11.798828
72
32
32.39844
293.3125
2.199707
2.899902
1.299805
139
7.179688
null
null
null
null
7
<2 mo. follow-up
7
11
1
81.44598
female
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
0
8
under $11k
0
13,105
10,368.3516
9,926.22656
11.5
white
17
21
0.845947
0.793945
1
0
0
no
0.7
0.5
no dnr
10
63
9.5
69
24
36
318.3125
4
0.699951
1.299805
135
7.439453
null
null
null
0
0
no(M2 and SIP pres)
0
1,811
0
77.008
male
1
11
ARF/MOSF w/Sepsis
ARF/MOSF
5
9
under $11k
9
20,080
15,475.9531
15,057.9688
19
white
18.199219
22
0.790894
0.721924
5
1
1
no
0.85
0.85
no dnr
11
126
6.599609
67
24
36
328.5625
2.699707
0.799927
0.899902
132
7.449219
null
null
null
null
7
<2 mo. follow-up
7
11
1
46.20099
female
0
19
ARF/MOSF w/Sepsis
ARF/MOSF
4
null
null
0
16,140
12,431.75
11,075.5391
10.333328
white
29.398438
37
0.793945
0.726929
1
1
0
no
0.9
0.85
no dnr
19
114
5
118
28
36
300
2.599609
3
0.5
135
7.419922
null
null
null
null
null
null
4.115234
1,527
1